Literature DB >> 12479224

The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

Andrei L Gartel1, Angela L Tyner.   

Abstract

Cancer develops when the balance between cell proliferation and cell death is disrupted, and the ensuing aberrant proliferation leads to tumor growth. The cyclin-dependent kinase inhibitor p21 is induced by both p53-dependent and -independent mechanisms following stress, and induction of p21 may cause cell cycle arrest. As a proliferation inhibitor, p21 is poised to play an important role in preventing tumor development. This notion is supported by data indicating that p21-null mice are more prone to spontaneous and induced tumorigenesis, and p21 synergizes with other tumor suppressors to protect against tumor progression in mice. However, a number of recent studies have pointed out that in addition to being an inhibitor of cell proliferation, p21 acts as an inhibitor of apoptosis in a number of systems, and this may counteract its tumor-suppressive functions as a growth inhibitor. In the current review, we discuss the role of p21 in regulating cell death and the potential relevance of its expression in cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479224

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  325 in total

Review 1.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

2.  PUMA mediates the apoptotic response to p53 in colorectal cancer cells.

Authors:  Jian Yu; Zhenghe Wang; Kenneth W Kinzler; Bert Vogelstein; Lin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

Review 3.  Cell cycle genes in a mouse mammary hyperplasia model.

Authors:  Thenaa K Said; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

4.  Pattern of expression of p53, its family members, and regulators during early ocular development and in the post-mitotic retina.

Authors:  Linda Vuong; Daniel E Brobst; Anisse Saadi; Ivana Ivanovic; Muayyad R Al-Ubaidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-20       Impact factor: 4.799

5.  Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

6.  Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells.

Authors:  Prabodh K Kandala; Sanjay K Srivastava
Journal:  Mol Pharmacol       Date:  2010-05-05       Impact factor: 4.436

7.  In rat renal fibroblasts, mycophenolic acid inhibits proliferation and production of the chemokine CCL2, stimulated by tumour necrosis factor-alpha.

Authors:  Hong-Wei Chang; Vin-Cent Wu; Kwan-Dun Wu; Hong-Yu Huang; Bor-Shen Hsieh; Yung-Ming Chen
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 8.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

9.  PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells.

Authors:  Zhu Yuan; Wenhao Guo; Jun Yang; Lei Li; Meiliang Wang; Yi Lei; Yang Wan; Xinyu Zhao; Na Luo; Ping Cheng; Xinyu Liu; Chunlai Nie; Yong Peng; Aiping Tong; Yuquan Wei
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

10.  Hypertonic Saline Primes Activation of the p53-p21 Signaling Axis in Human Small Airway Epithelial Cells That Prevents Inflammation Induced by Pro-inflammatory Cytokines.

Authors:  Fabia Gamboni; Cameron Anderson; Sanchayita Mitra; Julie A Reisz; Travis Nemkov; Monika Dzieciatkowska; Kenneth L Jones; Kirk C Hansen; Angelo D'Alessandro; Anirban Banerjee
Journal:  J Proteome Res       Date:  2016-08-29       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.